Mehrul Hasnain

St John's
NL A1E4J8, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

QTc Prolongation and Psychotropic Medications.

QTc Prolongation and Psychotropic Medications.

Journal: The American journal of psychiatry

Published: March 03, 2020

Use of Placebo in Clinical Trials of Psychotropic Medication.

Use of Placebo in Clinical Trials of Psychotropic Medication.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: April 19, 2018

Schizophrenia and metabolic dysregulation: shared roots?

Schizophrenia and metabolic dysregulation: shared roots?

Journal: The lancet. Psychiatry

Published: August 27, 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: August 04, 2016

Genetic vulnerability in antipsychotic drug-induced diabetes.

Genetic vulnerability in antipsychotic drug-induced diabetes.

Journal: The lancet. Psychiatry

Published: June 19, 2015

QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Journal: CNS drugs

Published: August 30, 2014

Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.

Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.

Journal: Therapeutic advances in infectious disease

Published: August 29, 2014

Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.

Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.

Journal: Therapeutic advances in infectious disease

Published: August 29, 2014

Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.

Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.

Journal: Therapeutic advances in infectious disease

Published: August 29, 2014

Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Journal: Therapeutic advances in drug safety

Published: August 13, 2014

Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Journal: Therapeutic advances in psychopharmacology

Published: July 25, 2014

Quetiapine and the need for a thorough QT/QTc study.

Quetiapine and the need for a thorough QT/QTc study.

Journal: Journal of clinical psychopharmacology

Published: December 19, 2013

Showing 1-12 of 32

Last Updated: 09/26/2026